CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research develops polymerized RNA nanoparticles for targeted drug delivery, particularly for treating fibrotic diseases. By using engineered microneedles, the project aims to enhance the effectiveness of therapies that promote the regeneration of heart tissue.
My research aims to advance drug delivery by developing multi-silencing polymerized RNA nanoparticles (Multi-R-NPs) for customized treatments across a wide range of diseases, using engineered microneedles to enhance efficacy.
This versatile platform can be adapted for applications such as stem cell differentiation and biosensing, with immediate potential to treat fibrotic diseases like cardiac and pulmonary fibrosis, reducing preventable mortality and improving patient quality of life.
Therapeut…
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
